Novel blood-based biomarker panels for the diagnosis and staging of Non-Alcoholic Fatty Liver disease
November 2, 2022Non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver disease, with a prevalence of 25% in the general population, 40% in the obese […]